Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. [electronic resource]
- The Cochrane database of systematic reviews 11 2019
Antibodies, Monoclonal--therapeutic use Antineoplastic Agents--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Bortezomib--therapeutic use Humans Lenalidomide--therapeutic use Multiple Myeloma--drug therapy Network Meta-Analysis Randomized Controlled Trials as Topic Thalidomide--therapeutic use